These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4152333)

  • 1. [Behaviour and properties of poliomyelitis coproantibodies using the "antiglobin test" and the conventional neutralisation test (author's transl)].
    Albano A; De Donato S; Scarinci V; Jakschik M
    Zentralbl Bakteriol Orig A; 1974 Feb; 226(1):1-11. PubMed ID: 4152333
    [No Abstract]   [Full Text] [Related]  

  • 2. [Humoral antibodies, coproantibodies and viral excretion in newborn infants immunized with poliomyelitis vaccine].
    Ruíz-Gómez J; Caloca García MA; Longega Escobio P
    Salud Publica Mex; 1979; 21(2):127-34. PubMed ID: 231330
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the neutralization of poliovirus by fecal immunoglobulins. The development of intestinal IgA antibodies following oral poliovirus immunization.
    Keller R; Dwyer JE
    Prog Immunobiol Stand; 1970; 4():316-22. PubMed ID: 4320518
    [No Abstract]   [Full Text] [Related]  

  • 4. [Findings of virus-neutralizing antibodies against polioviruses in the population of Slovakia 9 and 12 years following introduction of immunization by attenuated polioviruses (author's transl)].
    Borská K; Mayerová A; Masár I; Svanigová L; Roda J; Lukácová V
    Bratisl Lek Listy; 1976 Apr; 65(4):400-6. PubMed ID: 183864
    [No Abstract]   [Full Text] [Related]  

  • 5. Antipoliomyelitis program in Brazil; a erologic study of immunity levels.
    de Brito Bastos NC; Carvalho Filho ES de+CARVALHOAAFILHO ES; Schatzmayr H; Homma A; Chaves J
    Bull Pan Am Health Organ; 1974; 8(1):54-65. PubMed ID: 4423450
    [No Abstract]   [Full Text] [Related]  

  • 6. [Revaccination by oral monovalent poliovaccine type 3 (author's transl)].
    Srámová H; Teplý V; Bernatziková V
    Cesk Epidemiol Mikrobiol Imunol; 1981 Mar; 30(2):95-100. PubMed ID: 6261973
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the immunological situation seven years after the introduction into Italy of poliomyelitis vaccination with attenuated live virus vaccine].
    Squeri L; Calisto ML; Sindoni L; Mattace-Raso G
    Ann Sclavo; 1973; 15(1):1-18. PubMed ID: 4775017
    [No Abstract]   [Full Text] [Related]  

  • 8. Poliovirus antibody differentiation. Methods and application for strain specific diagnosis in complications after oral vaccination.
    Kuwert E; Höher PG; Thraenhart O
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):407-12. PubMed ID: 180727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poliovirus antibody in children from a paediatric hospital in Ibadan, Nigeria.
    Williams JO; David-West TS
    Rev Roum Virol; 1990; 41(2):129-32. PubMed ID: 2176534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [IgM-specific neutralizing antibodies against poliovirus in cases of poliomyelitis].
    Salmerón García F
    Bol Oficina Sanit Panam; 1982 Mar; 92(3):203-7. PubMed ID: 6279126
    [No Abstract]   [Full Text] [Related]  

  • 11. Poliomyelitis vaccines: an appraisal after 25 years.
    Melnick JL
    Compr Ther; 1980 Jan; 6(1):6-14. PubMed ID: 7357844
    [No Abstract]   [Full Text] [Related]  

  • 12. Herd immunity to poliovirus in Dundee.
    Smith WC; Small RG; Dunkerley RA; Green DM
    Health Bull (Edinb); 1982 Nov; 40(6):296-305. PubMed ID: 6298147
    [No Abstract]   [Full Text] [Related]  

  • 13. Persistence of poliovirus neutralizing antibodies eight years after immunization with live, attenuated-virus vaccine.
    Rousseau WE; Noble GR; Tegtmeier GE; Jordan MC; Chin TD
    N Engl J Med; 1973 Dec; 289(25):1357-9. PubMed ID: 4356637
    [No Abstract]   [Full Text] [Related]  

  • 14. Eradication of poliomyelitis in Cuba: a historical perspective.
    Más Lago P
    Bull World Health Organ; 1999; 77(8):681-7. PubMed ID: 10516790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Poliovirus-neutralizing antibodies in stools of poliomyelitis patients].
    Mazur B
    Przegl Epidemiol; 1971; 25(2):241-9. PubMed ID: 4328089
    [No Abstract]   [Full Text] [Related]  

  • 16. [Neutralizing antibodies in the sera of persons vaccinated with intradermal poliovirus vaccine].
    Jarzabek Z; Kańtoch M
    Przegl Epidemiol; 1984; 38(3):323-6. PubMed ID: 6098935
    [No Abstract]   [Full Text] [Related]  

  • 17. A seroprevalence study of poliovirus antibody in the population of northern Greece.
    Frantzidou F; Diza E; Halkia D; Antoniadis A
    Clin Microbiol Infect; 2005 Jan; 11(1):68-71. PubMed ID: 15649308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The status of poliomyelitis in Venezuela.
    Echezuría E
    Bull Pan Am Health Organ; 1974; 8(1):66-71. PubMed ID: 4371606
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serodiagnosis of poliomyelitis and prevention using an oral vaccine].
    Hara M
    Nihon Rinsho; 1990 Feb; 48 Suppl():348-51. PubMed ID: 2162425
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.
    Dragunsky EM; Ivanov AP; Wells VR; Ivshina AV; Rezapkin GV; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
    J Infect Dis; 2004 Oct; 190(8):1404-12. PubMed ID: 15378432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.